Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.
about
Emerging drugs for uveitisPars Planitis: Epidemiology, Clinical Characteristics, Management and Visual PrognosisIntraocular Implants for the Treatment of Autoimmune UveitisThe Future Is Now: Biologics for Non-Infectious Pediatric Anterior UveitisInvasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsTumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseasesResponse of pediatric uveitis to tumor necrosis factor-α inhibitors.Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors.Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitisPhlyctenular keratoconjunctivitis - an atypically severe case treated with systemic biologic immunosuppressive therapy.Pharmacotherapy of scleritis: current paradigms and future directions.Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience.High dose infliximab in the treatment of refractory uveitis: does dose matter?The role of biologic agents in the management of non-infectious uveitis.Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis.TNF inhibition for ophthalmic indications: current status and outlook.Emerging drugs for the treatment of uveitis.Management of pediatric uveitis.Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis.An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results.Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.Treatment strategies for childhood noninfectious chronic uveitis: an update
P2860
Q24630848-8A9FF9D0-14B1-43F8-9751-3CA6BE4D51BEQ26751204-0E12C26D-4A49-482B-ACF5-A6F98A74EC14Q26799168-901D8303-1314-4E08-B4D8-892705A4EF4BQ27025862-5C87604B-6A82-45DE-A2DE-A5871CEEAF39Q29302324-27E51438-A1B9-4DDA-9EC5-5C1117CB32D9Q33891912-5FCBBA65-5F95-4FDB-B589-3524B88AA771Q34789195-E29DD9F8-6CA5-447B-9FA2-3080CC0B4ABBQ35150941-F7D9EEBD-C1C8-4214-917E-50308D2E9688Q35904466-0AF2D37D-F758-4528-9BAF-19E1058D6176Q37095406-30DC0960-F6FD-4C4B-B89E-EED540445D52Q37115017-AE083EB2-429B-4299-809E-FB171BC8444BQ37241289-CC17A16B-71ED-4D2E-BEBB-309C90EDF51DQ37466204-B8E32EB2-0EA0-4F2A-9D64-996F40EFD52FQ37650221-B6BA30E2-817F-4A0E-B182-3B0F17A1473DQ37990508-BD3E8D68-A9F0-4D8D-833C-4BE46CE9D6E4Q38025152-B1B3B697-FD46-4E66-B37F-D90B9FF54B3AQ38074446-32EC7FF6-A04B-42CC-96B1-AF31AFEEA143Q38097327-AE5BD6C6-CAFB-4A7B-9B6D-E1DEAFD49055Q38166016-BF1D5819-451E-4288-8301-38E80C937E8FQ38225872-8F3EF137-82A3-4D47-8859-F01421E6EBF1Q38664517-16F83295-8B4C-4EAB-BA5C-566F439F6CA8Q38711172-1FA1154B-51DF-4C9D-9CB4-884903618B04Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18Q41994612-7E011BFF-EFF6-4419-8B0B-AE47004B26BBQ45911665-6C90DCE0-0C1A-4977-BF0A-A290B48D6A6AQ50788220-9453EAFF-DE84-4D6A-A48E-5199900E0A50Q58326249-267C17C3-5933-4F49-98FF-4E94B01B94A5
P2860
Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Infliximab to treat chronic no ...... ries with long-term follow-up.
@ast
Infliximab to treat chronic no ...... ries with long-term follow-up.
@en
type
label
Infliximab to treat chronic no ...... ries with long-term follow-up.
@ast
Infliximab to treat chronic no ...... ries with long-term follow-up.
@en
prefLabel
Infliximab to treat chronic no ...... ries with long-term follow-up.
@ast
Infliximab to treat chronic no ...... ries with long-term follow-up.
@en
P2093
P2860
P1476
Infliximab to treat chronic no ...... ries with long-term follow-up.
@en
P2093
Deborah Kredich
Egla Rabinovich
Glenn J Jaffe
Laura E Schanberg
Stacy P Ardoin
P2860
P304
P356
10.1016/J.AJO.2007.08.018
P407
P577
2007-10-22T00:00:00Z